Our First Target Market is the Treatment of Tinea Pedis and Onychomycosis Conditions

MARKET OPPORTUNITY
Infectious Skin Disease Market Growth 2018-2025 E
In Millions of USD

Sales of OTC and prescription infectious disease therapies are estimated at more than $8.0 B by 2025.


Topical anti-fungal market within Dermatology specialty markets annualized sales of $ 3.0 B.

Our Path to Commercialization